Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Recruiting 198Active not recruiting 158Not yet recruiting 39Suspended 21Terminated 4Completed 4Withdrawn 2Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1Breast 1

Conditions

Recurrence 1Prostatic Neoplasms 1Patient Compliance 1Myelodysplastic Syndromes 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Breast Neoplasms 1

Interventions

pembrolizumab 26Cisplatin 14Nivolumab 11Cyclophosphamide 11Carboplatin 11Paclitaxel 9Docetaxel 9Radiotherapy, Intensity-Modulated 8Radiotherapy 8Magnetic Resonance Spectroscopy 8Radiosurgery 7Radiation 7Fluorouracil 7Bevacizumab 7Leucovorin 6Irinotecan 6Gemcitabine 6Doxorubicin 6venetoclax 5olaparib 5enzalutamide 5Prednisone 5Pemetrexed 5Oxaliplatin 5Metformin 5Azacitidine 5fludarabine 4atezolizumab 4Taxes 4Surveys and Questionnaires 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Specimen Handling × 30 days × Clear all
NCT04183218 2026-05-27

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Mayo Clinic

Completed
24 enrolled 27 charts
Thoracic

Lung Neoplasms

NCT05564650 2026-05-19

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Thomas Jefferson University

Phase 1 Completed
6 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT05730712 2026-05-15

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Mayo Clinic

Phase 2 Completed
7 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT06635005 2026-05-11

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Completed
34 enrolled
Breast

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡